ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism / Q000648:ultrastructure; D066298:In Vitro Techniques; D007700:Kinetics; D009284:Naphthols / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism*; D013347:Subcellular Fractions / Q000378:metabolism; D013570:Synaptic Membranes / Q000378:metabolism; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism; D013764:Tetrahydronaphthalenes / Q000378:metabolism; D013997:Time Factors
D009284:Naphthols; D011954:Receptors, Dopamine; D013764:Tetrahydronaphthalenes; D011188:Potassium; D002118:Calcium